June 2024 FDA Recall Methylphenidate Hydrochloride by Trigen Laboratories
D-0579-2024 - Failed dissolution specifications

This Class II drug recall was voluntarily initiated by Trigen Laboratories on June 17, 2024 for the product Methylphenidate Hydrochloride. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0579-2024

Reason for Recall
Failed dissolution specifications: this product is being recalled due to this batch not meeting dissolution specifications.
Initiated
06-17-2024
Reported
07-10-2024
Quantity
10,448 100-count bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide in the USA
Methylphenidate Hydrochloride, Extended-release Tablets, USP, 36mg, 100-count Bottle, Rx Only, Manufactured for: Trigen Laboratories, LLC, Alpharetta, GA 30005, NDC 13811-708-10

Batch or Lot Expiration Information

Lot# Lot 230159M, Exp Date 2/28/2026